6.
Wang X, Cui L, Wang Y, Zeng Z, Wang H, Tian L
. Mechanistic investigation of wogonin in delaying the progression of endothelial mesenchymal transition by targeting the TGF-β1 pathway in pulmonary hypertension. Eur J Pharmacol. 2024; 978:176786.
DOI: 10.1016/j.ejphar.2024.176786.
View
7.
Isobe S, Nair R, Kang H, Wang L, Moonen J, Shinohara T
. Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension. Nat Commun. 2023; 14(1):7578.
PMC: 10663616.
DOI: 10.1038/s41467-023-43039-y.
View
8.
Swaneck G, Fishman J
. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci U S A. 1988; 85(21):7831-5.
PMC: 282290.
DOI: 10.1073/pnas.85.21.7831.
View
9.
Pan Z, Wu X, Zhang X, Hu K
. Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling. Biomed Pharmacother. 2022; 158:114095.
DOI: 10.1016/j.biopha.2022.114095.
View
10.
Fishman J
. Aromatic hydroxylation of estrogens. Annu Rev Physiol. 1983; 45:61-72.
DOI: 10.1146/annurev.ph.45.030183.000425.
View
11.
Santillo A, Falvo S, Di Fiore M, Chieffi Baccari G
. Seasonal changes and sexual dimorphism in gene expression of StAR protein, steroidogenic enzymes and sex hormone receptors in the frog brain. Gen Comp Endocrinol. 2016; 246:226-232.
DOI: 10.1016/j.ygcen.2016.12.012.
View
12.
Landeros R, Jobe S, Aranda-Pino G, Lopez G, Zheng J, Magness R
. Convergent ERK1/2, p38 and JNK mitogen activated protein kinases (MAPKs) signalling mediate catecholoestradiol-induced proliferation of ovine uterine artery endothelial cells. J Physiol. 2017; 595(14):4663-4676.
PMC: 5509880.
DOI: 10.1113/JP274119.
View
13.
Olivieri F, Albertini M, Orciani M, Ceka A, Cricca M, Procopio A
. DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging. Oncotarget. 2015; 6(34):35509-21.
PMC: 4742121.
DOI: 10.18632/oncotarget.5899.
View
14.
Mannisto P, Kaakkola S
. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999; 51(4):593-628.
View
15.
Taraseviciute A, Voelkel N
. Severe pulmonary hypertension in postmenopausal obese women. Eur J Med Res. 2006; 11(5):198-202.
View
16.
Cui J, Li G, Yin J, Li L, Tan Y, Wei H
. GSTP1 and cancer: Expression, methylation, polymorphisms and signaling (Review). Int J Oncol. 2020; 56(4):867-878.
DOI: 10.3892/ijo.2020.4979.
View
17.
Xu W, Koeck T, Lara A, Neumann D, DiFilippo F, Koo M
. Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A. 2007; 104(4):1342-7.
PMC: 1783136.
DOI: 10.1073/pnas.0605080104.
View
18.
Cohen E, Ihida-Stansbury K, Lu M, Panettieri R, Jones P, Morrisey E
. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J Clin Invest. 2009; 119(9):2538-49.
PMC: 2735923.
DOI: 10.1172/JCI38079.
View
19.
Hood K, Montezano A, Harvey A, Nilsen M, MacLean M, Touyz R
. Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Mediated Redox Signaling and Vascular Remodeling by 16α-Hydroxyestrone in Human Pulmonary Artery Cells: Implications in Pulmonary Arterial Hypertension. Hypertension. 2016; 68(3):796-808.
PMC: 4978604.
DOI: 10.1161/HYPERTENSIONAHA.116.07668.
View
20.
Chen X, Talati M, Fessel J, Hemnes A, Gladson S, French J
. Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism. Circulation. 2015; 133(1):82-97.
PMC: 4698046.
DOI: 10.1161/CIRCULATIONAHA.115.016133.
View